对 J.-Y. Blay 等人撰写的手稿 "对有高复发风险的局部 GIST 患者进行 6 年与 3 年伊马替尼辅助治疗的随机研究 "的答复Blay et al.

{"title":"对 J.-Y. Blay 等人撰写的手稿 \"对有高复发风险的局部 GIST 患者进行 6 年与 3 年伊马替尼辅助治疗的随机研究 \"的答复Blay et al.","authors":"F Petrelli, L Dottorini, A Ghidini","doi":"10.1016/j.annonc.2024.09.012","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":" ","pages":"1206-1207"},"PeriodicalIF":56.7000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reply to the manuscript 'A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse' by J.-Y. Blay et al.\",\"authors\":\"F Petrelli, L Dottorini, A Ghidini\",\"doi\":\"10.1016/j.annonc.2024.09.012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":8000,\"journal\":{\"name\":\"Annals of Oncology\",\"volume\":\" \",\"pages\":\"1206-1207\"},\"PeriodicalIF\":56.7000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.annonc.2024.09.012\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/9/19 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.annonc.2024.09.012","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/19 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}